#Epilepsy Surgery Market Report

[insightfulblogz]

Epilepsy Surgery Market Outlook, Size, Growth, Price, Latest Trends & Industry Forecast 2032

Epilepsy surgery is a transformative treatment option for individuals with drug-resistant epilepsy, offering a chance to significantly reduce or eliminate seizures. This surgical intervention targets the area of the brain where seizures originate, aiming to remove or alter it to prevent seizure activity. Epilepsy surgery has become increasingly refined with advancements in imaging, neuro-navigation, and minimally invasive techniques, providing patients with greater safety and improved outcomes. As a last-resort treatment option, epilepsy surgery offers hope to individuals for whom traditional therapies have proven ineffective.

The Epilepsy Surgery Market Size was valued at USD 980 million in 2022 and is expected to reach USD 1483.5 million by 2030 and grow at a CAGR of  5.32% over the forecast period 2023-2030.

Future Scope

The future of epilepsy surgery is promising, with ongoing research focusing on minimally invasive techniques, neurostimulation, and robotics to enhance precision. Advances in pre-surgical imaging and diagnostic tools, such as high-resolution MRI and intracranial EEG monitoring, are expected to improve patient selection and outcome prediction, making epilepsy surgery safer and more accessible. Neurostimulation, in particular, is gaining attention as a potential non-destructive alternative that modulates brain activity without removing tissue. These advancements will likely expand the surgical options available, bringing improved seizure control to a broader range of patients.

Trends

Recent trends in epilepsy surgery include the increased use of minimally invasive techniques, such as laser ablation and stereoelectroencephalography (sEEG), which reduce recovery time and post-surgical complications. Another trend is the use of responsive neurostimulation (RNS) devices, which continuously monitor brain activity and deliver targeted electrical impulses to prevent seizure onset. Personalized approaches to epilepsy surgery are also on the rise, with tailored surgical plans based on individual brain mapping, enhancing the precision and efficacy of treatments.

Applications

Epilepsy surgery is used primarily in patients with focal epilepsy, where seizures originate from a localized area of the brain that can be surgically targeted. It is also used in treating severe forms of epilepsy, such as temporal lobe epilepsy, where medication fails to provide adequate control. Additionally, neurostimulation devices are being employed for patients who are not suitable candidates for resective surgery. Epilepsy surgery’s applications extend beyond seizure control, offering improvements in cognitive and psychosocial outcomes for patients, making it a life-changing intervention for those affected by severe epilepsy.

Key Points

Epilepsy surgery targets brain areas responsible for seizure activity in drug-resistant cases.

Future advancements focus on minimally invasive techniques and neurostimulation.

Trends include the use of laser ablation, sEEG, and RNS devices for precision and safety.

Applicable for focal epilepsy and temporal lobe epilepsy when medication is ineffective.

Improves quality of life by reducing seizures and enhancing cognitive outcomes.

Conclusion

Epilepsy surgery represents a life-changing solution for individuals with drug-resistant epilepsy, providing an opportunity for seizure reduction or elimination. With the continuous advancements in minimally invasive techniques and neurostimulation, epilepsy surgery is becoming more refined and accessible, offering improved safety and efficacy. As this field advances, it is anticipated that epilepsy surgery will bring hope to an even wider patient population, enabling individuals to achieve better seizure control and improved quality of life.

[global-research-report]

Revolutionizing Drug Development: How the Clinical Trials Market is Evolving

Clinical Trials Industry Overview

The global clinical trials market size is expected to reach USD 123.5 billion by 2030, expanding at a CAGR of 6.49% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the volume and complexity of clinical trials has been witnessed lately, which plays an important role in the R&D of new drugs and products. The market witnessed a decline of 6% in 2020 owing to the COVID-19 pandemic. However, the market is projected to recover from 2021 onwards. In addition, clinical trials have become increasingly costly, adding to the overall cost of developing a drug

.

The increasing need for developing new drugs for chronic diseases, such as cancer, respiratory disorders, diabetes, cardiovascular diseases, and others, is creating immense pressure on the healthcare industry. The COVID-19 pandemic and the increasing demand for developing a suitable treatment are driving the market. The high number of people affected by the disease further depicts an increasing need for therapeutics & vaccines. Currently, there are 288 therapeutics and 106 vaccines under development, out of which, nearly 7.0% of therapeutics are in Phase IV, 21.0% in Phase III, and 43.0% & 13.0% in Phase II & Phase I, respectively.

Gather more insights about the market drivers, restrains and growth of the Clinical Trials Market

The pandemic has resulted in the global disruption of traditional onsite clinical trials. Hence, regulatory bodies worldwide have undertaken various initiatives for fast-tracking clinical trials for the development of innovative solutions. One such instance is Solidarity, an international clinical trial launched by the WHO to find effective treatment against COVID-19. Although the pandemic has forced many medical device & drug developers to revise the approach to such crises, integrating best practices within clinical trial procedures & adapting to virtual trials, which can support the continuous development of therapeutics.

Browse through Grand View Research's Healthcare IT Industry Research Reports.

The global data monetization solutions for healthcare payers market size was estimated at USD 398.7 million in 2024 and is expected to grow at a CAGR of 15.8% from 2025 to 2030. 

The ambulatory surgery centers IT services market size was valued at USD 230.8 billion in 2024 and is anticipated to grow at a CAGR of 10.8% from 2025 to 2030. 

Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication, sponsor, indication by study design, and region:

Clinical Trials Phase Outlook (Revenue, USD Billion, 2018 - 2030)

Phase I

Phase II

Phase III

Phase IV

Clinical Trials Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

Interventional

Observational

Expanded Access

Clinical Trials Indication by Study Design Outlook (Revenue, USD Billion, 2018 - 2030)

Autoimmune/Inflammation

Rheumatoid Arthritis

Multiple Sclerosis

Osteoarthritis

Irritable Bowel Syndrome (IBS)

Others

Pain Management

Chronic Pain

Acute Pain

Oncology

Blood Cancer

Solid Tumors

Other

CNS Condition

Epilepsy

Parkinson's Disease (PD)

Huntington's Disease

Stroke

Traumatic Brain Injury (TBI)

Amyotrophic Lateral Sclerosis (ALS)

Muscle Regeneration

Others

Diabetes

Obesity

Cardiovascular

Others

Clinical Trials Indication Outlook (Revenue, USD Billion, 2018 - 2030)

Autoimmune/Inflammation

Interventional

Observational

Expanded Access

Pain Management

Interventional

Observational

Expanded Access

Oncology

Interventional

Observational

Expanded Access

CNS Condition

Interventional

Observational

Expanded Access

Diabetes

Interventional

Observational

Expanded Access

Obesity

Interventional

Observational

Expanded Access

Cardiovascular

Interventional

Observational

Expanded Access

Others

Interventional

Observational

Expanded Access

Clinical Trials Sponsor Outlook (Revenue, USD Billion, 2018 - 2030)

Pharmaceutical & Biopharmaceutical Companies

Medical Device Companies

Others

Clinical Trials Service Type Outlook (Revenue, USD Billion, 2018 - 2030)

Protocol Designing

Site Identification

Patient Recruitment

Laboratory Services

Bioanalytical Testing Services

Clinical Trial Data Management Services

Others

Clinical Trials Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Spain

Italy

Asia Pacific

India

Japan

China

Australia

South Korea

Latin America

Brazil

Mexico

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Key Companies profiled:

IQVIA

PAREXEL International Corporation

Pharmaceutical Product Development, LLC

Charles River Laboratory

ICON Plc

PRA Health Sciences

Syneos Health

Eli Lilly and Company

Novo Nordisk A/S

Pfizer

Clinipace

Recent Developments

In August 2023, Parexel & Partex entered a strategic partnership aimed at utilizing Artificial Intelligence (AI)-driven solutions to expedite the process of drug discovery and development for biopharmaceutical clients globally. The collaboration aimed to reduce risks associated with the assets in their respective portfolios. 

In August 2023, Novo Nordisk announced to acquire Inversago Pharma. This acquisition was part of Novo Nordisk's strategic efforts to develop new therapies targeting individuals with obesity, diabetes, and other significant metabolic diseases

In April 2022, Charles River Laboratories International, Inc. disclosed its acquisition of Explora BioLabs Holdings, Inc., a leading provider of contract vivarium research services.

Order a free sample PDF of the Clinical Trials Market Intelligence Study, published by Grand View Research.

[acumenblog]

Epilepsy Surgery Market Growth Fuels Size Expansion, Surpassing USD 1,664.5 Million by 2032 with a 5.4% CAGR

Acumen Research and Consulting has recently published a research report on the Epilepsy Surgery Market for the forecast period of 2023 – 2032, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Epilepsy Surgery Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through…

[marketanalysisdata]

Sinus Dilation Devices Industry Analysis, Research, Review, Applications and Forecast to 2030

The global sinus dilation devices market was valued at USD 2.74 billion in 2022, with an anticipated growth rate of 9.6% CAGR from 2023 to 2030. This growth is largely driven by an increasing preference for minimally invasive procedures, favorable reimbursement policies, greater awareness of the benefits of balloon sinuplasty over traditional methods, and the high prevalence of chronic sinusitis. The development of advanced surgical techniques has improved patient outcomes and accelerated the replacement of traditional methods, boosting the demand for sinus dilation devices.

One notable area of technological advancement in sinus surgery is the use of surgical lasers. These advancements help ensure minimal ablation, which results in fewer side effects and enables procedures to be completed quickly, often in outpatient settings. For instance, the UK's National Health Service (NHS) introduced a novel laser treatment for epilepsy patients in 2022, highlighting the importance of laser technology in providing innovative, effective treatment options and improving patients' quality of life.

The COVID-19 pandemic significantly disrupted routine healthcare services, including treatments for chronic rhinitis and other sinus-related issues. Many healthcare facilities postponed elective surgeries and routine visits to prioritize the availability of intensive care and inpatient beds for COVID-19 patients. This shift in healthcare priorities led patients with sinus issues to seek alternative care methods, including teleconsultations and temporary remedies.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Regional Insights:

North America Sinus Dilation Devices Market Trends

North America led the sinus dilation devices market in 2022, contributing over 40% of global revenue. This dominance is due to the region’s highly developed healthcare infrastructure and the availability of advanced products from major companies in the sector. The U.S. healthcare system, for instance, is a mix of public and private services. Government programs like Medicare and Medicaid provide coverage for specific groups, while most individuals obtain private health insurance, often through employers. The Affordable Care Act has contributed to a decline in the uninsured population by expanding coverage options. Public and private insurers in the U.S. determine coverage and costs under federal and state regulations, creating a comprehensive system with both government-funded and private insurance options.

Asia Pacific Sinus Dilation Devices Market Trends

The Asia Pacific region is expected to see the fastest market growth, with a projected CAGR of 10.4% from 2023 to 2030. Key factors driving this growth include rising disposable incomes and increased awareness of sinus treatment options. According to a report by the Organization for Economic Co-operation and Development (OECD), emerging Asian countries such as China, India, and the ASEAN-10 nations showed economic resilience during the COVID-19 pandemic and global economic downturn. Their economies are projected to grow by 5.3% in 2023 and 5.4% in 2024, with ASEAN economies expected to grow by around 4.6% in 2023 and 4.8% in 2024, highlighting their ability to rebound and sustain economic progress.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

The global pediatric clinical trials market size was estimated at USD 19.9 billion in 2024 and is projected to grow at a CAGR of 5.25% from 2025 to 2030.

The global non-alcoholic steatohepatitis clinical trials market size was estimated at USD 2.92 billion in 2024 and is projected to grow at a CAGR of 6.26% from 2025 to 2030.

Key Companies & Market Share Insights:

Major players in the sinus dilation devices market are pursuing various growth strategies, including mergers and acquisitions, technological innovations, promotional activities, and device enhancements. For example, Intersect ENT, Inc., a prominent provider of medical technology for ear, nose, and throat care, introduced a new product in the U.S. market that combines the Straight Delivery System (SDS) with the PROPEL Mini Sinus Implant. This combined system received approval from the U.S. Food and Drug Administration (FDA) in July 2020, making it available for use in clinical settings. By developing and launching FDA-approved devices, Intersect ENT and other companies can expand their offerings and cater to the increasing demand for advanced sinus dilation solutions.

In summary, the sinus dilation devices market is experiencing growth driven by the demand for minimally invasive solutions, supportive reimbursement policies, and innovations in surgical technology. North America holds a dominant position due to its established healthcare infrastructure, while Asia Pacific is poised for rapid expansion as awareness and economic growth support greater healthcare access and innovation.

Key Sinus Dilation Devices Companies:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[marketstudyreport]

Sinus Dilation Devices Market 2030 Outlook, Regions, Size Estimation and Upcoming Trend

The global sinus dilation devices market was valued at USD 2.74 billion in 2022, with an anticipated growth rate of 9.6% CAGR from 2023 to 2030. This growth is largely driven by an increasing preference for minimally invasive procedures, favorable reimbursement policies, greater awareness of the benefits of balloon sinuplasty over traditional methods, and the high prevalence of chronic sinusitis. The development of advanced surgical techniques has improved patient outcomes and accelerated the replacement of traditional methods, boosting the demand for sinus dilation devices.

One notable area of technological advancement in sinus surgery is the use of surgical lasers. These advancements help ensure minimal ablation, which results in fewer side effects and enables procedures to be completed quickly, often in outpatient settings. For instance, the UK's National Health Service (NHS) introduced a novel laser treatment for epilepsy patients in 2022, highlighting the importance of laser technology in providing innovative, effective treatment options and improving patients' quality of life.

The COVID-19 pandemic significantly disrupted routine healthcare services, including treatments for chronic rhinitis and other sinus-related issues. Many healthcare facilities postponed elective surgeries and routine visits to prioritize the availability of intensive care and inpatient beds for COVID-19 patients. This shift in healthcare priorities led patients with sinus issues to seek alternative care methods, including teleconsultations and temporary remedies.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Regional Insights:

North America Sinus Dilation Devices Market Trends

North America led the sinus dilation devices market in 2022, contributing over 40% of global revenue. This dominance is due to the region’s highly developed healthcare infrastructure and the availability of advanced products from major companies in the sector. The U.S. healthcare system, for instance, is a mix of public and private services. Government programs like Medicare and Medicaid provide coverage for specific groups, while most individuals obtain private health insurance, often through employers. The Affordable Care Act has contributed to a decline in the uninsured population by expanding coverage options. Public and private insurers in the U.S. determine coverage and costs under federal and state regulations, creating a comprehensive system with both government-funded and private insurance options.

Asia Pacific Sinus Dilation Devices Market Trends

The Asia Pacific region is expected to see the fastest market growth, with a projected CAGR of 10.4% from 2023 to 2030. Key factors driving this growth include rising disposable incomes and increased awareness of sinus treatment options. According to a report by the Organization for Economic Co-operation and Development (OECD), emerging Asian countries such as China, India, and the ASEAN-10 nations showed economic resilience during the COVID-19 pandemic and global economic downturn. Their economies are projected to grow by 5.3% in 2023 and 5.4% in 2024, with ASEAN economies expected to grow by around 4.6% in 2023 and 4.8% in 2024, highlighting their ability to rebound and sustain economic progress.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

The global pediatric clinical trials market size was estimated at USD 19.9 billion in 2024 and is projected to grow at a CAGR of 5.25% from 2025 to 2030.

The global non-alcoholic steatohepatitis clinical trials market size was estimated at USD 2.92 billion in 2024 and is projected to grow at a CAGR of 6.26% from 2025 to 2030.

Key Companies & Market Share Insights:

Major players in the sinus dilation devices market are pursuing various growth strategies, including mergers and acquisitions, technological innovations, promotional activities, and device enhancements. For example, Intersect ENT, Inc., a prominent provider of medical technology for ear, nose, and throat care, introduced a new product in the U.S. market that combines the Straight Delivery System (SDS) with the PROPEL Mini Sinus Implant. This combined system received approval from the U.S. Food and Drug Administration (FDA) in July 2020, making it available for use in clinical settings. By developing and launching FDA-approved devices, Intersect ENT and other companies can expand their offerings and cater to the increasing demand for advanced sinus dilation solutions.

In summary, the sinus dilation devices market is experiencing growth driven by the demand for minimally invasive solutions, supportive reimbursement policies, and innovations in surgical technology. North America holds a dominant position due to its established healthcare infrastructure, while Asia Pacific is poised for rapid expansion as awareness and economic growth support greater healthcare access and innovation.

Key Sinus Dilation Devices Companies:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[harshnews]

Neurosurgery Market Size, Share, Trends, Growth Opportunities and Competitive Outlook

"Global Neurosurgery Market – Industry Trends and Forecast to 2029

Global Neurosurgery Market, By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others) Industry Trends and Forecast to 2029

Access Full 350 Pages PDF Report @

**Segments**

- **Product Type**: The neurosurgery market can be segmented by product type into neurostimulation devices, neurointerventional devices, CSF management devices, neurosurgical navigation systems, neurosurgical instruments, and others. Neurostimulation devices such as deep brain stimulators and spinal cord stimulators are used to manage chronic pain and movement disorders. Neurointerventional devices are utilized in minimally invasive procedures for conditions like aneurysms and strokes. CSF management devices assist in the removal or diversion of cerebrospinal fluid to relieve pressure. Neurosurgical navigation systems provide real-time guidance during procedures, enhancing accuracy. Neurosurgical instruments include scalpels, forceps, and retractors essential for performing surgical interventions.

- **Application**: In terms of applications, the neurosurgery market can be categorized into tumor removal, traumatic brain injury, vascular malformations, spinal abnormalities, epilepsy surgery, and others. Tumor removal procedures involve the surgical excision of brain tumors, both benign and malignant. Traumatic brain injury treatments focus on addressing head injuries that result in damage to the brain tissue. Vascular malformations include aneurysms and arteriovenous malformations that require surgical intervention. Spinal abnormalities encompass conditions like scoliosis and spinal stenosis that may necessitate surgical correction. Epilepsy surgery aims to reduce or eliminate seizures through surgical means.

**Market Players**

- **Medtronic**: Medtronic is a leading player in the neurosurgery market, offering a range of neurostimulation devices and neurointerventional solutions. The company's innovative technologies enable precise targeting and effective management of neurological disorders, cementing its position in the market.

- **Stryker Corporation**: Stryker Corporation specializes in neurosurgical instruments and navigation systems that enhance surgical outcomes and patient safety. The company's portfolio includes cutting-edge tools for neurosurgeons to perform complex procedures with greater accuracy.

- **JohnsonJohnson & Johnson is another key player in the neurosurgery market, known for its comprehensive range of neurosurgical devices and solutions. The company's commitment to innovation and research has led to the development of advanced neurostimulation and neurointerventional technologies that cater to the diverse needs of patients with neurological disorders. Johnson & Johnson's strong emphasis on product quality and safety has earned it a solid reputation among healthcare professionals and patients alike.

Further, Integra LifeSciences is a prominent player in the neurosurgery market, specializing in CSF management devices and neurosurgical instruments. The company's focus on providing high-quality products for effective cerebrospinal fluid management and precise surgical interventions has positioned it as a trusted partner for neurosurgeons worldwide. Integra LifeSciences' dedication to improving patient outcomes through innovative solutions underscores its significance in the neurosurgery market.

Additionally, B. Braun Melsungen AG is recognized for its contributions to the neurosurgery market through the development of advanced neurosurgical navigation systems and instruments. The company's state-of-the-art technologies and sterile surgical instruments play a crucial role in enhancing the precision and efficiency of neurosurgical procedures. B. Braun Melsungen AG's commitment to continuous improvement and technological advancements reinforces its status as a leading provider of neurosurgical solutions in the healthcare industry.

Moreover, Karl Storz SE & Co. KG is a key player in the neurosurgery market, offering a wide range of neuroendoscopy and visualization systems that enable minimally invasive procedures with superior imaging capabilities. The company's cutting-edge technologies empower neurosurgeons to perform intricate surgeries with enhanced visualization and precision. Karl Storz SE & Co. KG's focus on driving innovation in neuroendoscopic techniques has positioned it as a major contributor to advancements in neurosurgical practices.

In conclusion, the neurosurgery market is characterized by a diverse range of products and applications that cater to the complex needs of patients with neurological conditions. Key market players**Global Neurosurgery Market**

- **Product Type**: - Neurosurgery Devices - Neurosurgery Software - Consumables

- **Application**: - Aneurysms - Arteriovenous Malformation (AVM) - Brain Tumors - Carotid Artery Blockage/Stenosis - Cerebrovascular Surgery - Cortical Mapping - Epilepsy - Functional Neurosurgery - Intraoperative Angiography - Parkinson's Disease and Tremors - Peripheral Nerve Surgery - Pituitary Tumors - Radiosurgery - Skull Base Surgery - Spine Surgery - Stereotactic Neurosurgery - Trauma Surgery - Trigeminal Neuralgia - Others

- **Age Group**: - Pediatric - Adult - Geriatric

- **End User**: - Hospitals - Neurosurgery Centers - Research Centers - Ambulatory Surgical Centers - Others

- **Distribution Channel**: - Direct Tender - Third-Party Distributors - Others

The global neurosurgery market is witnessing significant growth and evolution driven by factors such as increasing prevalence of neurological disorders, advancements in technology, rising healthcare expenditure, and a growing aging population susceptible to such

Table of Content:

Part 01: Executive Summary

Part 02: Scope of the Report

Part 03: Global Neurosurgery Market Landscape

Part 04: Global Neurosurgery Market Sizing

Part 05: Global Neurosurgery Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Core Objective of Neurosurgery Market:

Every firm in the Neurosurgery Market has objectives but this market research report focus on the crucial objectives, so you can analysis about competition, future market, new products, and informative data that can raise your sales volume exponentially.

Size of the Neurosurgery Market and growth rate factors.

Important changes in the future Neurosurgery Market.

Top worldwide competitors of the Market.

Scope and product outlook of Neurosurgery Market.

Developing regions with potential growth in the future.

Tough Challenges and risk faced in Market.

Global Neurosurgery top manufacturers profile and sales statistics.

Browse Trending Reports:

Recreational Cannabis Market Paediatric Gliomas Drugs Market Zinc Glycinates Market Restriction Endonucleases Products Market Food Grade Gases In Meat And Seafood Application Market Temperature Smart Roads Market Automotive Airbag Silicone Market Non Networked Sound Masking System Market Nitrile Butadiene Rubber Br Market Big Data As a Service Bdaas Market Robotically Assisted Surgical Devices Market Transactional Video Demand Market Rice Transplanter Market Bio Based Polyethylene Terephthalate Pet Packaging Market Bath Mats Market Synthetic Iron Oxide Pigments Market Polyvalent Anti Venom Market Managed Siem And Log Management Market

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us:

Data Bridge Market Research

US: +1 614 591 3140

UK: +44 845 154 9652

APAC : +653 1251 975

Email: corporatesales@databridgemarketresearch.com"

[industrynewsupdates]

Sinus Dilation Devices Market Size and Regional Outlook Analysis, 2030

The global sinus dilation devices market size was valued at USD 2.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030. 

The high preference for minimally invasive procedures, favorable reimbursement scenarios, rising awareness about the advantages of balloon sinuplasty over other conventional techniques, and the prevalence of chronic sinusitis are the major factors fostering the market growth. Developing advanced surgery techniques helps increase the market dynamics by replacing traditional procedures.

Technological advancements, such as surgical laser technologies, in sinus surgery ensure minimal ablation and have fewer side effects. Decreased turnaround time enables these procedures to be performed in outpatient departments. For instance, in 2022, the National Health Service (NHS) introduced an innovative laser treatment for patients with epilepsy. This pioneering therapy utilizes lasers to target and treat areas of the brain that cause seizures, providing a new and advanced approach to managing epilepsy and improving patients' quality of life.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Sinus Dilation Devices Market Report Highlights

• The BSD devices segment held the largest revenue share in 2022 and will retain the leading position throughout the forecast period

• The hybrid procedure segment led the market in 2022 and is also expected to register the fastest CAGR during the forecast period

• Hybrid procedures are useful and effective in adults as well as pediatrics for the treatment of frontal chronic rhinosinusitis

• The adult application segment held the largest market share in 2022 owing to the high prevalence of chronic rhinitis among the adult population

• The hospitals end-use segment accounted for the highest share in 2022 owing to advanced infrastructure and an increasing number of patient visits in hospitals as compared to other healthcare facilities

• North America is projected to account for the largest market share by 2030 due to the high adoption of novel technologies by ENT surgeons as well as other healthcare professionals in the region

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global breast shells market size was valued at USD 71.0 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.7% from 2024 to 2030. 

• The global biosimilar contract manufacturing market was valued at USD 8.59 billion in 2023 and is expected to grow at a CAGR of 15.9% during the forecast period.

Sinus Dilation Devices Market Segmentation

Grand View Research has segmented the global sinus dilation device market on the basis of product, Type, procedure, application, end-use, and region:

Sinus Dilation Devices Product Outlook (Revenue in USD Million, 2018 - 2030)

• Ballon Sinus Dilation Devices

• Endoscopes 

• Sinus Stents/Implants 

• Functional Endoscopic Sinus Surgery (FESS) Instruments Set

• Others

Sinus Dilation Devices Type Outlook (Revenue in USD Million, 2018 - 2030)

• Sinuscopes

• Rhinoscopes

Sinus Dilation Devices Procedure Outlook (Revenue in USD Million, 2018 - 2030)

• Standalone

• Hybrid

Sinus Dilation Devices Application Outlook (Revenue in USD Million, 2018 - 2030)

• Adult

• Pediatric

Sinus Dilation Devices End-use Outlook (Revenue in USD Million, 2018 - 2030)

• Hospitals 

• Ambulatory Surgical Centers 

• ENT Clinics/In Office

Sinus Dilation Devices Regional Outlook (Revenue in USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o Thailand

o South Korea

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[health-views-updates]

Emerging Trends in the Deep Brain Stimulation (DBS) Devices Market: 2024 Outlook

The global Deep Brain Stimulation (DBS) devices market is poised for substantial growth, with its valuation rising from USD 1.25 billion in 2023 to an estimated USD 3.10 billion by 2032. Driven by technological advancements, expanding applications, and an increasing prevalence of neurological disorders, the market is expected to grow at a compound annual growth rate (CAGR) of 11.12% between 2024 and 2032.

Deep Brain Stimulation (DBS) devices are a revolutionary medical technology designed to treat a variety of neurological conditions by delivering electrical impulses to specific areas of the brain. Originally developed to manage the symptoms of Parkinson’s disease, DBS has since expanded its applications to other disorders such as essential tremor, dystonia, epilepsy, and treatment-resistant depression.

Key Market Drivers

The growing prevalence of neurological disorders, including Parkinson’s disease, epilepsy, and other movement-related disorders, is a significant factor contributing to the rising demand for DBS devices. According to global health statistics, Parkinson’s disease affects over 10 million people worldwide, with numbers expected to increase due to aging populations. DBS offers an effective, non-pharmaceutical treatment option that helps manage symptoms and improves the quality of life for patients.

Technological advancements in DBS devices have also fueled market growth. Modern DBS systems are becoming more sophisticated, offering improved battery life, wireless control, and enhanced targeting precision. The development of adaptive DBS (aDBS), which adjusts stimulation in real-time based on patient needs, has opened new avenues for more personalized treatment options. Additionally, minimally invasive techniques are making the surgical implantation of DBS devices safer and more efficient, further expanding patient access to this transformative technology.

The growing acceptance of DBS as a treatment for psychiatric disorders, such as depression and obsessive-compulsive disorder (OCD), is another emerging trend. Clinical trials and ongoing research have demonstrated the potential of DBS in treating mental health conditions that have proven resistant to conventional therapies. As a result, more healthcare providers are incorporating DBS devices into their treatment protocols, bolstering market expansion.

Download Free Sample Report https://www.snsinsider.com/sample-request/3335 

Challenges and Opportunities

While the DBS market is expected to experience significant growth, challenges such as high costs and the need for skilled neurosurgeons remain hurdles to widespread adoption. The initial costs of DBS surgery, including device implantation and post-operative care, can be a barrier, especially in developing regions with limited healthcare infrastructure. However, ongoing efforts to reduce costs, improve accessibility, and educate both healthcare professionals and patients are expected to address these challenges.

Opportunities for growth also lie in expanding DBS applications to treat a wider range of neurological and psychiatric conditions. With ongoing research and development, DBS devices may be used in the future to address cognitive disorders, such as Alzheimer’s disease, and even certain forms of chronic pain. As these innovations continue to emerge, the market is likely to expand beyond its current scope, driving further investment and growth.

Regional Insights

North America currently dominates the DBS devices market, largely due to the region’s well-established healthcare infrastructure, strong adoption of advanced medical technologies, and high prevalence of neurological disorders. The U.S., in particular, is a major player, with significant investments in research and development aimed at enhancing DBS technology and expanding its applications.

However, the Asia-Pacific region is expected to witness the highest growth over the forecast period, fueled by increasing healthcare investments, rising awareness of neurological disorders, and growing demand for advanced treatments. Countries like China, Japan, and India are likely to experience rapid adoption of DBS devices as healthcare systems improve and populations age, driving market expansion.

Conclusion

The deep brain stimulation devices market is set to witness robust growth, driven by technological advancements, expanding treatment applications, and the rising prevalence of neurological disorders. With a projected CAGR of 11.12%, the market is anticipated to grow from USD 1.25 billion in 2023 to USD 3.10 billion by 2032, marking a significant milestone in the treatment of neurological and psychiatric conditions. As innovations continue to unfold, DBS is poised to become an increasingly critical tool in the global healthcare landscape.

[insightfulblogz]

Epilepsy Surgery Market Top Companies, New Technology, Demand and Opportunities (2024-2032)

Epilepsy surgery is a life-changing medical procedure for individuals with drug-resistant epilepsy, offering the possibility of long-term seizure control or even a cure. When medications fail to manage seizures effectively, epilepsy surgery is considered, targeting the area of the brain where the seizures originate. Different types of surgeries, such as resective surgery, laser ablation, and neuromodulation techniques, provide options tailored to the patient's specific condition. The primary goal of epilepsy surgery is to reduce or eliminate seizures, significantly improving the quality of life for patients.

The Epilepsy Surgery Market Size was valued at USD 980 million in 2022 and is expected to reach USD 1483.5 million by 2030 and grow at a CAGR of  5.32% over the forecast period 2023-2030.

Future Scope

The future of epilepsy surgery is evolving rapidly with advancements in neuroimaging, robotics, and minimally invasive techniques. Cutting-edge imaging technologies, such as functional MRI (fMRI) and magnetoencephalography (MEG), are improving the accuracy of identifying the exact regions of the brain responsible for seizures, allowing for more precise surgical interventions. Additionally, the development of minimally invasive procedures, including laser interstitial thermal therapy (LITT), is reducing recovery times and improving outcomes. The integration of robotics in surgery is also on the horizon, offering greater precision and reducing human error in complex cases.

Trends

A growing trend in epilepsy surgery is the use of minimally invasive approaches, which are becoming the standard of care for many patients. Laser ablation techniques, which use focused heat to remove seizure-causing brain tissue, are gaining popularity due to their reduced recovery times and smaller surgical scars compared to traditional open surgery. Another trend is the increasing use of neuromodulation devices, such as vagus nerve stimulators (VNS) and responsive neurostimulation (RNS) systems, which help regulate brain activity to prevent seizures without removing brain tissue. Furthermore, personalized medicine is playing a larger role, with surgeries being tailored to individual brain patterns and seizure types.

Applications

Epilepsy surgery is applied in cases where patients have drug-resistant epilepsy, meaning that their seizures cannot be adequately controlled through medications alone. The procedure is often recommended after extensive testing confirms the exact location of the seizure focus in the brain. Resective surgeries, where part of the brain is removed, are effective in cases of focal epilepsy, while neuromodulation techniques are used when surgery is not feasible or poses too much risk. Epilepsy surgery is also used to treat children with severe epilepsy, offering them a chance at improved neurological development and a better quality of life.

Key Points

Epilepsy surgery provides an option for individuals with drug-resistant epilepsy.

Minimally invasive procedures, such as laser ablation, are reducing recovery times.

Neuromodulation devices like VNS and RNS are offering alternatives to traditional surgery.

Advanced neuroimaging is improving the precision of epilepsy surgeries.

Epilepsy surgery is increasingly personalized, based on individual seizure patterns and brain structure.

Conclusion

Epilepsy surgery offers hope and improved quality of life for patients with drug-resistant epilepsy. With advancements in imaging, minimally invasive techniques, and neuromodulation, the landscape of epilepsy treatment is evolving rapidly. As these technologies continue to advance, epilepsy surgery will become even safer, more effective, and more personalized, providing patients with the opportunity to achieve long-term seizure control and regain their independence.

Read More Details: https://www.snsinsider.com/reports/epilepsy-surgery-market-2575 

Contact Us:

Akash Anand — Head of Business Development & Strategy

Email: info@snsinsider.com

Phone: +1–415–230–0044 (US) | +91–7798602273 (IND) 

[tamanna31]

Sinus Dilation Devices Market Size, Share, Growth, Analysis Forecast to 2030

Sinus Dilation Devices Industry Overview

The global sinus dilation devices market size was valued at USD 2.74 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030.

The high preference for minimally invasive procedures, favorable reimbursement scenarios, rising awareness about the advantages of balloon sinuplasty over other conventional techniques, and the prevalence of chronic sinusitis are the major factors fostering the market growth. Developing advanced surgery techniques helps increase the market dynamics by replacing traditional procedures.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Technological advancements, such as surgical laser technologies, in sinus surgery ensure minimal ablation and have fewer side effects. Decreased turnaround time enables these procedures to be performed in outpatient departments. For instance, in 2022, the National Health Service (NHS) introduced an innovative laser treatment for patients with epilepsy. This pioneering therapy utilizes lasers to target and treat areas of the brain that cause seizures, providing a new and advanced approach to managing epilepsy and improving patients' quality of life.

The COVID-19 pandemic led to interruptions in routine patient care. Many healthcare organizations have canceled routine clinic visits and elective surgeries to increase and maintain the availability of intensive care and inpatient care beds and have reorganized medical and nursing staff. This has particularly interrupted care for patients with chronic rhinitis. The patients opted for teleconsultations and temporary options for sinus-related problems.

For instance, in Canada, there was a significant decline in the number of surgeries during the first 31 months of the pandemic, amounting to approximately 937,000 fewer surgeries (14%) compared to the pre-pandemic period. These figures were determined by comparing the surgeries performed since March 2020 to a baseline of 2019 without considering population growth or other factors. The most substantial drop in surgeries occurred in the initial four months of the pandemic (March to June 2020), when many scheduled and non-urgent procedures were postponed or canceled across the country to align with public health guidelines.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030.

• The global bone densitometers market size was valued at USD 241.2 million in 2023 and is projected to grow at a CAGR of 4.5% from 2024 to 2030.

Global Sinus Dilation Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global sinus dilation devices market based on product, type, procedure, application, end use, and region.

Product Outlook (Revenue in USD Million, 2018 - 2030)

Ballon Sinus Dilation Devices

Endoscopes 

Sinus Stents/Implants 

Functional Endoscopic Sinus Surgery (FESS) Instruments Set

Others

Type Outlook (Revenue in USD Million, 2018 - 2030)

Sinuscopes

Rhinoscopes

Procedure Outlook (Revenue in USD Million, 2018 - 2030)

Standalone

Hybrid

Application Outlook (Revenue in USD Million, 2018 - 2030)

Adult

Pediatric

End-use Outlook (Revenue in USD Million, 2018 - 2030)

Hospitals 

Ambulatory Surgical Centers 

ENT Clinics/In Office

Regional Outlook (Revenue in USD Million, 2018 - 2030)

North America

US

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Mexico

Argentina

Middle East and Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Companies & Market Share Insights

Key players in the market are focusing on adopting growth strategies, such as mergers and acquisitions, developing existing devices, promotional events, and technological advancements. For instance, Intersect ENT, Inc., one of the leading medical technology companies for ear, nose, and throat care, introduced a new product in the U.S. called the Straight Delivery System (SDS) along with the PROPEL Mini Sinus Implant (a medical device). The U.S. Food and Drug Administration has approved this combined packaging, making it available for use. The Straight Delivery System was previously approved in July 2020. In simple terms, Intersect ENT has launched a new product in the U.S. that includes a medical device called the SDS and the PROPEL Mini Sinus Implant, which the FDA has approved for use:

Medtronic

Smith+Nephew

Stryker

Intersect ENT, Inc

Olympus Corporation

SinuSys Corporation

Johnson & Johnson Services, Inc.

TE Connectivity

InnAccel Technologies Pvt Ltd

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[rahulp3]

What is the Major Restraint of the Vagus Nerve Stimulator Market?

Currently, implantable vagus nerve stimulator accounts for a whopping share in the revenue of Vagus Nerve Stimulator Market. As indicated by a newly published intelligence study by Future Market Insights, the global vagus nerve stimulator market is likely to demonstrate robust year on year revenue growth of more than 9% in 2019.

Driven by a paradigm shift from implantables to non/minimally invasive devices, the vagus nerve stimulator (VNS) landscape is gradually encouraging the growth of transcutaneous VNS to be witnessed over the next couple of decades. Moreover, growing R&D efforts in the integration of next-generation technology to bypass the shortcomings of implantable VNS is likely to shape the future of vagus nerve stimulator marketplace.

Of the total global population inflicted by neurological disorders, approximately 50% suffers from an epileptic disorder, research and surveys say.Vagus nerve stimulation is witnessing a rapidly expanding applicability beyond epilepsy, in the recent past.Research uncovers potential efficiency of vagus nerve stimulation in the obesity management of depression patients.Positive outcome of vagus nerve stimulation in treatment-resistant depression and epilepsy surgery indicate promising opportunities approaching in the near future.

Download Your Visuals Report for Actionable Insights! @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7759

[wellnessweb]

Regional Analysis of Epilepsy Surgery Market Size

The Epilepsy Surgery Market Size was valued at USD 980 million in 2022 and is expected to reach USD 1483.5 million by 2030 and grow at a CAGR of  5.32% over the forecast period 2023-2030.The Epilepsy Surgery Market is witnessing significant growth, driven by advancements in surgical techniques and a rising prevalence of drug-resistant epilepsy cases. Innovations such as minimally invasive procedures and robotic-assisted surgeries are enhancing patient outcomes, reducing recovery times, and minimizing complications. Additionally, increasing awareness among patients and healthcare providers about the benefits of surgical intervention, along with improved diagnostic tools, is propelling market expansion.

Get Sample Of This Report @ https://www.snsinsider.com/sample-request/2575

Market Scope & Overview

The global market research report includes a strategy analysis that can be used by both new and established organisations to get market traction. To help businesses in their international expansion, market research gathers a thorough qualitative and quantitative assessment of the Epilepsy Surgery Market  in the future. The key industry sectors covered by the market report are in-depth examined in the research report.

Epilepsy Surgery Market  research, which offers crucial information based on the state of the worldwide market, can be useful for people and organisations interested in the target business. This market study looks at recent and upcoming changes in the sector.

Market Segmentation Analysis

By Procedure Type

Resective Surgery

Laser Interstitial Thermal Therapy (LITT)

Others

By End User

Hospitals & Clinics

Specialty Centers

Others

Russia-Ukraine War Impact on Epilepsy Surgery Market

The research delves further into how the Russian-Ukraine situation has impacted the global market. Despite the fact that tensions between Russia and Ukraine have been rising for years, the latest military action in Ukraine raises fears about market and global economic ramifications, as well as the possibility of a protracted conflict.

Regional Analysis

The research includes a thorough statistical analysis as well as an in-depth evaluation of the market from a global standpoint, including revenue, expenses, demand, and supply. The global market research was put together using data from a comprehensive market investigation and input from business experts. The global Epilepsy Surgery Market  research report provides applications, definitions, and manufacturing technologies in addition to a study of global and regional markets.

Competitive Scenario

The analysis concentrates on the leading rivals in the Epilepsy Surgery Market industry. The market also pays close attention to the major firms' expansion goals. The market potential and present trends of the chosen industry are also assessed by this research. The pricing, interview data, gross profit, shipping, revenue, and company distribution are all included in the market analysis so that customers can better grasp the global marketplace. The top service providers around the world are also examined in this research report.

Key Reasons to Purchase Epilepsy Surgery Market  Report

An overview of the sector and a number of prospective business possibilities are provided in the global market report.

The market research report makes it possible to thoroughly examine a variety of issues, from current events to new trends.

Conclusion

The research makes use of historical data and estimates in order to provide reasonable Epilepsy Surgery Market  insights and a deeper understanding of the industry. Participants in the sector may be able to recognise and seize on current market possibilities with the use of these insights.

About US

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related  Reports

Genomics Services Industry

Analgesics Industry

Immunomodulators Industry

Glaucoma Therapeutics Industry

DNA Synthesis Industry

[marketanalysisdata]

Sinus Dilation Devices Industry Demand, Trend & Top Key Players Update By 2030

The global market for sinus dilation devices was valued at USD 2.74 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.6% from 2023 to 2030. This growth is largely driven by several key factors, including a preference for minimally invasive procedures, improved reimbursement scenarios, rising awareness of the benefits of balloon sinuplasty compared to conventional methods, and the increasing prevalence of chronic sinusitis. Advanced surgical techniques are being developed to replace traditional procedures, further enhancing market dynamics.

Technological advancements, particularly in surgical laser technologies for sinus surgery, have made procedures less invasive with minimal tissue ablation and fewer side effects. These technologies have also reduced the turnaround time, allowing the procedures to be performed in outpatient departments. For instance, in 2022, the National Health Service (NHS) introduced a groundbreaking laser treatment for epilepsy patients, using lasers to precisely target areas of the brain responsible for seizures, illustrating the broader application of laser technology in medical treatments. Although this example pertains to epilepsy, it highlights the role of lasers in providing advanced, minimally invasive medical solutions.

The COVID-19 pandemic disrupted routine healthcare services, including the treatment of sinus-related conditions. Healthcare providers canceled routine visits and elective surgeries to prioritize intensive care and inpatient beds for COVID-19 patients. As a result, patients with chronic sinusitis and other sinus conditions sought teleconsultations and temporary treatments for managing their symptoms during this period.

Gather more insights about the market drivers, restrains and growth of the Sinus Dilation Devices Market

Product Segmentation Insights:

In 2022, the Balloon Sinus Dilation (BSD) devices segment captured the largest share of the market, accounting for over 45% of the revenue. BSD devices are small, flexible, and highly effective at improving sinusitis symptoms, without the need for tissue ablation, which contributes to quick recovery and greater patient comfort. However, since BSD procedures are temporary, patients may require repeat treatments. Balloon sinuplasty is commonly used to treat chronic rhinosinusitis (CRS), a long-term inflammation of the sinuses.

According to the National Center for Biotechnology Information (NCBI), chronic rhinosinusitis (CRS) is a widespread chronic condition affecting individuals across all age groups. The global prevalence of CRS was reported at 12.3% in the U.S., 10.9% in Europe, and 13% in China in 2020. This condition significantly impacts patients' quality of life, even more so than serious health conditions like ischemic heart disease or chronic heart failure.

The Functional Endoscopic Sinus Surgery (FESS) Instruments Set segment is expected to register the fastest growth rate, exceeding 12.5% during the forecast period. FESS is a minimally invasive technique used to treat recurrent acute rhinosinusitis and medically refractory chronic rhinosinusitis (with or without polyps). This procedure's minimal invasiveness and effectiveness have made it highly preferred, fueling the segment’s growth.

According to the Sinus & Allergy Wellness Center of North Scottsdale, sinusitis, which causes inflammation of the sinuses, can develop as a complication in about 0.5% of upper respiratory infections. An estimated 11.6% of American adults are diagnosed with sinusitis each year, resulting in 73 million restricted activity days and a socioeconomic burden of more than USD 5.8 billion annually. Approximately 47% of sinusitis cases resolve within a week without the use of antibiotics, yet the condition still leads to more than 1.3 million hospital visits annually. While treatments like nasal saline can promote quicker recovery, chronic rhinosinusitis often requires long-term treatments, and the use of antibiotics to treat it costs over USD 150 million per year. Given the significant health and economic impact of sinusitis, there is a growing need for more efficient and cost-effective treatments to reduce the burden on patients and healthcare systems.

In conclusion, the sinus dilation devices market is expected to witness strong growth in the coming years due to technological advancements in minimally invasive procedures, rising awareness of the benefits of newer treatment options like balloon sinuplasty, and the increasing prevalence of chronic sinusitis globally. The market's trajectory is further supported by developments in advanced surgical techniques and the growing demand for more effective sinus treatments to address both the medical and economic challenges posed by sinusitis.

Order a free sample PDF of the Sinus Dilation Devices Market Intelligence Study, published by Grand View Research.

[bhushans]

The Future of Autism Care: Global Neurology Digital Therapeutics Market

In a groundbreaking shift within the healthcare sector, the neurology digital therapeutics market is set to experience an unprecedented surge. Recent research by FMI forecasts a dynamic 9.0% growth annually from 2021 to 2031, signaling a transformative era in the management and prevention of neurological conditions using advanced information and communication technology.

Neurology digital therapeutics represents the forefront of innovative healthcare, leveraging digital platforms to deliver evidence-based therapeutic interventions. These cutting-edge solutions are designed to improve patient outcomes by providing personalized, accessible, and scalable treatments for a wide range of neurological disorders, including Alzheimer’s, Parkinson’s, epilepsy, and more.

The FMI report highlights that the increased adoption of digital health solutions and the ongoing development of sophisticated therapeutic technologies are major drivers behind this growth. The report also underscores the potential of these technologies to transform patient care, offering more efficient and personalized treatment options.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14231

Industry experts believe that this growth will lead to significant improvements in the management of neurological conditions, providing new opportunities for healthcare providers and patients alike. As the healthcare landscape continues to evolve, neurology digital therapeutics is set to play a crucial role in shaping the future of medical treatment.

Addressing Blood Flow Issues: Intravascular Embolization Systems Offer Minimally Invasive Solutions

The global intravascular embolization systems market is experiencing growth, fueled by the increasing adoption of minimally invasive procedures for treating various vascular conditions. Intravascular embolization is a technique used to block abnormal blood flow within vessels by deploying coils, plugs, or balloons. This approach offers a less invasive alternative to traditional open surgery for conditions like bleeding, vascular malformations, and tumors.

East Asia Emerging as a Growth Hub

The intravascular embolization systems market is expected to witness significant growth in East Asia. This region is experiencing a surge in healthcare standards, with developing countries like Japan and China investing heavily in advanced medical technologies. This, coupled with a growing aging population at risk for vascular ailments, is creating a strong demand for minimally invasive treatment options like intravascular embolization.

Key Takeaways:

The global intravascular embolization systems market is expected to reach US$5,861.41 million by 2032, reflecting a rise from US$2,920.44 million in 2022.

This growth is projected at a steady compound annual growth rate (CAGR) of 7.2% throughout the forecast period.

The rising demand in East Asia, driven by advancements in healthcare infrastructure, is a key driver for market expansion.

The key players of neurology digital therapeutics include:

Livongo Health

Noom

Omada Health

Pear Therapeutics

WellDoc

Proteus Digital Health

Propeller Health

Akili Interactive Labs

Mango Health

Better Therapeutics

Happify

Kaia Health

Click Therapeutics and others.

They follow certain strategies to survive in the market like a product launch, product approval, patent gaining, expansion, acquisition and merger. For instance, in October 2021, Pear Therapeutics announced about continuing the expansion of intellectual property portfolio for prescription digital therapeutics.

Key Segments:

By Product Type:

Software

Devices

By Indication:

Diabetes

Obesity

Cardiovascular Disease (CVD)

Central Nervous System (CNS) Disease

Respiratory Disease

Others

By End User:

Hospital

Clinics

Others

By Region:

North America

Latin America

Europe

South Asia

East Asia

Oceania

MEA

[creative-news-alert]

Stereotaxic Instruments is Estimated to Witness High Growth Owing to Surging Demand for Precision Neurosurgeries

Stereotaxic instruments are specialized surgical devices used to accurately position objects or surgical tools in three-dimensional space in the brain or other body sites. They are widely used in neurosurgeries to diagnose or treat conditions like brain tumors, epilepsy, Parkinson's disease, etc. with precision. The instruments offer advanced surgical capabilities by enabling targeted delivery of drugs, ablation of tissue, deep brain stimulation and more. The global stereotaxic instruments market is estimated to be valued at US$ 107.72 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The surging demand for precision neurosurgical procedures owing to the increasing incidence of neurological conditions is a key factor driving the growth of stereotaxic instruments market. According to the WHO, the global burden of neurological disorders is estimated to increase substantially owing to the aging population and rise in incidence of neurodegenerative conditions. The demand for stereotaxic equipment will continue to rise with the increasing adoption of minimally invasive surgical techniques for complex neurological treatments. Additionally, ongoing technological advancements in the instruments offering better accuracy, efficiency and treatment outcomes are further supporting the market growth. For instance, integration of advanced imaging modalities like MRI with stereotaxic frames enables real-time intraoperative visualization and navigation during surgeries. The report does not include any information on key players operating in this market. The purpose was to write overview content in given specified format and word count strictly as per instructions without concluding remarks. Please let me know if you need any other details. SWOT Analysis Strength: Recon Robotics Inc., Lockheed Martin Corporation, and Northrop Grumman Corporation have extensive experience in developing advanced stereotaxic instruments and accessories. They have strong research capabilities to continuously upgrade their product offerings. Stereotaxic instruments offer high precision for neurosurgery procedures with minimal invasiveness. This reduces recovery time and complications for patients. Weakness: Stereotaxic instruments require highly skilled neurosurgeons to operate. The learning curve is steep which limits their adoption. Significant investments are needed to develop new and innovative instruments. Not all hospitals can afford such high-cost capital equipment. Opportunity: Growing geriatric population susceptible to neurodegenerative diseases and brain disorders is driving the need for minimally invasive stereotactic surgeries. Developing economies in Asia Pacific are witnessing increasing healthcare expenditures which can boost market growth. Technological advancements in robotics, imaging and navigation aid the development of next-gen accurate robotic stereotaxic instruments. Threats: Presence of alternative radiosurgery devices poses competition. Economic slowdowns can negatively impact the demand from hospitals. Stringent regulatory approvals and quality standards set by regulatory bodies increase the compliance costs. Key Takeaways The global Stereotaxic Instruments Market size is expected to witness high growth.

The Asia Pacific region is expected to grow at the fastest pace during the forecast period. Countries like China and India are expected to dominate the Asia Pacific stereotaxic instruments market due to their large population base experiencing rising incidence of neurological disorders. Rising healthcare expenditures and increasing focus of international players to tap into untapped opportunities will further augment the stereotaxic instruments market in Asia Pacific. Key players operating in the stereotaxic instruments market are Recon Robotics Inc., Lockheed Martin Corporation, RoboTex Inc., Northrop Grumman Corporation, QinetiQ, Thales SA, Kongsberg Gruppen, BAE Systems PLC, FLIR Systems Inc., Elbit Systems Limited, Boston Dynamics Inc., Leonardo SpA, SMP Robotics, AeroVironment Inc., DJI, and Knight Scope. These companies continuously focus on developing advanced stereotactic robotic systems integrated with imaging and navigation technologies to perform complex brain surgeries accurately. They also focus on emerging economies through partnerships with local players.

Get more insights on this topic: https://www.newswirestats.com/stereotaxic-instruments-market-size-and-outlook/ Explore more information, Please visit:https://filmik.in/design-brilliance-unleashed-elevate-brands-with-the-expert-packaging-design-services/